Single-Cell Analysis of Tfh ICOS and IL-21 Variation Links Local Immune Activation to Anti-Thyroid Antibodies in Graves’ Disease
DOI:
https://doi.org/10.58445/rars.3571Keywords:
Single-cell RNA sequencing, Autoimmune Disorder, T cell, BiologyAbstract
Graves’ disease (GD) is an autoimmune cause of hyperthyroidism in which T cell and B cell interactions drive thyroid autoantibody production. To test whether intrathyroid T follicular helper (Tfh) signatures relate to downstream immune activation, we analyzed single-cell RNA sequencing (scRNA-seq) data from GD and healthy thyroid tissue. Data were processed in Scanpy with filtering, normalization to 10,000 reads per cell and log-transformation, PCA (principal component analysis, summarizing gene expression into components that capture variation across cells), and Leiden clustering. Batch effects were addressed using BBKNN (Batch Balanced K-Nearest Neighbors), which builds a batch-balanced neighbor graph by selecting neighbors from each sample or batch. We examined Tfh-cell ICOS and IL21 because ICOS co-stimulation supports Tfh survival and IL-21 secretion, and IL-21 promotes B-cell activation and differentiation. ICOS expression was quantified as normalized ICOS transcript abundance in Tfh cells and summarized per donor. We integrated these signals with a per-sample B-cell activation index and serum anti-thyroglobulin (anti-TG) and anti-thyroid peroxidase (anti-TPO) titers.
At the donor level, mean Tfh ICOS expression was higher in GD than in controls but variable and did not separate groups (Welch’s t-test p = 0.302; healthy n = 4, GD n = 5). IL21 expression was low overall and similarly did not separate groups (p = 0.427). We therefore stratified GD donors into Tfh ICOS⁺ and Tfh ICOS⁻ subgroups. B-cell activation differed across Healthy, Tfh ICOS⁻, and Tfh ICOS⁺ groups (ANOVA p = 0.0013), with higher activation in Tfh ICOS⁺ donors. Serum anti-TG (ANOVA p = 0.0011) and anti-TPO (ANOVA p = 0.0289) were highest in the Tfh ICOS⁺ subgroup.
Together, these results suggest that heterogeneity in Tfh ICOS expression may mark a subset of GD donors with stronger B-cell activation and higher anti-thyroid antibodies, while highlighting power limits from small donor counts for donor-level comparisons.
References
Álvarez-Sierra, Daniel, Jorge Rodríguez-Grande, Aroa Gómez-Brey, et al. “Single Cell Transcriptomic Analysis of Graves’ Disease Thyroid Glands Reveals the Broad Immunoregulatory Potential of Thyroid Follicular and Stromal Cells and Implies a Major Re-Interpretation of the Role of Aberrant HLA Class II Expression in Autoimmunity.” Journal of Autoimmunity 139 (September 2023): 103072. https://doi.org/10.1016/j.jaut.2023.103072.
Bartalena, Luigi. “Graves’ Disease: Complications.” In Endotext, edited by Kenneth R. Feingold, Robert A. Adler, S. Faisal Ahmed, et al. MDText.com, Inc., 2000. http://www.ncbi.nlm.nih.gov/books/NBK285551/.
Bogusławska, Joanna, Marlena Godlewska, Ewa Gajda, and Agnieszka Piekiełko-Witkowska. “Cellular and Molecular Basis of Thyroid Autoimmunity.” European Thyroid Journal 11, no. 1 (2022): e210024. https://doi.org/10.1530/ETJ-21-0024.
Bossaller, Lukas, Jan Burger, Ruth Draeger, et al. “ICOS Deficiency Is Associated with a Severe Reduction of CXCR5+CD4 Germinal Center Th Cells.” Journal of Immunology (Baltimore, Md.: 1950) 177, no. 7 (2006): 4927–32. https://doi.org/10.4049/jimmunol.177.7.4927.
Choi, Youn Soo, Robin Kageyama, Danelle Eto, et al. “ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6.” Immunity 34, no. 6 (2011): 932–46. https://doi.org/10.1016/j.immuni.2011.03.023.
Crotty, Shane. “T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.” Immunity 50, no. 5 (2019): 1132–48. https://doi.org/10.1016/j.immuni.2019.04.011.
Ehlers, Margret, Stephanie Allelein, and Matthias Schott. “TSH-Receptor Autoantibodies: Pathophysiology, Assay Methods, and Clinical Applications.” Minerva Endocrinologica 43, no. 3 (2018): 323–32. https://doi.org/10.23736/S0391-1977.17.02791-2.
Eisenbarth, Stephanie C., Dirk Baumjohann, Joe Craft, et al. “CD4+ T Cells That Help B Cells - a Proposal for Uniform Nomenclature.” Trends in Immunology 42, no. 8 (2021): 658–69. https://doi.org/10.1016/j.it.2021.06.003.
“Hyperthyroidism.” American Thyroid Association, n.d. Accessed December 26, 2025. https://www.thyroid.org/hyperthyroidism/.
Ji, Qianfei, Hong Xu, Haiyan Chen, Xiangfang Chen, Suijun Wang, and Junjie Zou. “Pathogenic Genes Associated with Immune-Related Genes in Graves’ Disease: A Multi-Omics Mendelian Randomization Analysis.” Scientific Reports 15, no. 1 (2025): 37875. https://doi.org/10.1038/s41598-025-21754-4.
Jovic, Dragomirka, Xue Liang, Hua Zeng, Lin Lin, Fengping Xu, and Yonglun Luo. “Single-Cell RNA Sequencing Technologies and Applications: A Brief Overview.” Clinical and Translational Medicine 12, no. 3 (2022): e694. https://doi.org/10.1002/ctm2.694.
Kim, Dong Won, Kamil Taneja, Thanh Hoang, et al. “Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.” Investigative Ophthalmology & Visual Science 62, no. 9 (2021): 24. https://doi.org/10.1167/iovs.62.9.24.
Martínez-Hernández, Rebeca, Nuria Sánchez de la Blanca, Pablo Sacristán-Gómez, et al. “Unraveling the Molecular Architecture of Autoimmune Thyroid Diseases at Spatial Resolution.” Nature Communications 15, no. 1 (2024): 5895. https://doi.org/10.1038/s41467-024-50192-5.
Pokhrel, Binod, and Kamal Bhusal. “Graves Disease.” In StatPearls. StatPearls Publishing, 2025. http://www.ncbi.nlm.nih.gov/books/NBK448195/.
Polański, Krzysztof, Matthew D Young, Zhichao Miao, Kerstin B Meyer, Sarah A Teichmann, and Jong-Eun Park. “BBKNN: Fast Batch Alignment of Single Cell Transcriptomes.” Bioinformatics 36, no. 3 (2020): 964–65. https://doi.org/10.1093/bioinformatics/btz625.
Pontarini, Elena, William James Murray-Brown, Cristina Croia, et al. “Unique Expansion of IL-21+ Tfh and Tph Cells under Control of ICOS Identifies Sjögren’s Syndrome with Ectopic Germinal Centres and MALT Lymphoma.” Annals of the Rheumatic Diseases 79, no. 12 (2020): 1588–99. https://doi.org/10.1136/annrheumdis-2020-217646.
Stoeckius, Marlon, Christoph Hafemeister, William Stephenson, et al. “Simultaneous Epitope and Transcriptome Measurement in Single Cells.” Nature Methods 14, no. 9 (2017): 865–68. https://doi.org/10.1038/nmeth.4380.
Vogelzang, Alexis, Helen M. McGuire, Di Yu, Jonathan Sprent, Charles R. Mackay, and Cecile King. “A Fundamental Role for Interleukin-21 in the Generation of T Follicular Helper Cells.” Immunity 29, no. 1 (2008): 127–37. https://doi.org/10.1016/j.immuni.2008.06.001.
Wolf, F. Alexander, Philipp Angerer, and Fabian J. Theis. “SCANPY: Large-Scale Single-Cell Gene Expression Data Analysis.” Genome Biology 19, no. 1 (2018): 15. https://doi.org/10.1186/s13059-017-1382-0.
Wong, Siew-Cheng, Edwin Oh, Chee-Hoe Ng, and Kong-Peng Lam. “Impaired Germinal Center Formation and Recall T-Cell-Dependent Immune Responses in Mice Lacking the Costimulatory Ligand B7-H2.” Blood 102, no. 4 (2003): 1381–88. https://doi.org/10.1182/blood-2002-08-2416.
Zhao, Lianyu, Song Jin, Shengyao Wang, et al. “Tertiary Lymphoid Structures in Diseases: Immune Mechanisms and Therapeutic Advances.” Signal Transduction and Targeted Therapy 9 (August 2024): 225. https://doi.org/10.1038/s41392-024-01947-5.
Downloads
Posted
Categories
License
Copyright (c) 2026 Joydeep Basu

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license